Article summary
Last week, the DEA moved to place five little-known psychedelic compounds — 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, and DiPT — into Schedule I of the Controlled Substances Act. It’s the agency’s second attempt at this exact scheduling action; it withdrew an earlier version in 2022 after pushback from researchers and legal advocates. We don’t advocate for… Continue reading Statement on DEA attempt to reschedule five tryptamines
Continue to the original publication for the complete article.